We're looking forward to next week's Goldman Sachs Global Healthcare Conference, where our CEO, Roger M. Perlmutter, and CFO, Alfred (Freddie) Bowie, will be providing important business updates and highlighting the exciting progress of our lead clinical programs, along with key data presented at the recent #AACR24 and #ASCO24 meetings. To learn more and access an archived recording of the presentation, please visit: www.EikonTx.com/news. #TeamEikon #Biotech
Eikon Therapeutics
Biotechnology Research
Hayward, CA 18,998 followers
Pioneering a new method of drug discovery based on tracking and measuring movement of individual proteins in live cells
About us
Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the interface of biology, engineering and chemistry to discover novel treatments for life-threatening diseases. Eikon’s discovery platform is built on groundbreaking innovations from its founders (Nobel Prize, 2014), culminating in the creation of microscopes which enable real time, molecular-resolution measurements of protein movement in living cells. By directly measuring the effects of chemical compounds on the behavior of protein molecules in a live cellular environment, Eikon’s landmark assays facilitate the highly sensitive identification of compound-protein interactions that could not be identified through traditional assays, thereby unlocking otherwise intractable classes of proteins as drug targets. Furthermore, the ability to directly visualize protein mechanisms in disease coupled with the extraordinarily high-powered high-content data sets generated by Eikon’s drug-screening technology enable an unprecedented opportunity to quantitatively explore novel biology in the living cell. These insights facilitate creation and application of data-driven hypotheses to the discovery of life-saving therapies. Eikon is seeking adventurous, passionate and creative team members eager to apply their talents to empower interdisciplinary scientific exploration, inaugurate a radical drug-discovery paradigm, and ultimately create novel medicines. To learn more about open positions, please visit: https://eikontx.com/team#positions
- Website
-
http://www.eikontx.com
External link for Eikon Therapeutics
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- Hayward, CA
- Type
- Privately Held
- Founded
- 2019
Locations
-
Primary
3929 Point Eden Way
Hayward, CA 94545, US
Employees at Eikon Therapeutics
-
Aaron Klammer
- Software Development - Bioinformatics - Team Leadership - Creating tools to help separate knowledge from noise
-
Mengjuei (MJ) H.
A computer programmer at Eikon Therapeutics. I care about the sciences of a problem to be resolved, the performance of computation, the build…
-
John Shin
-
Russ Berman
Chief Technology Officer & Executive Vice President at Eikon Therapeutics
Updates
-
If you’re keen to learn more about Eikon's progress over recent months, check us out at ASCO (and link below), follow on LinkedIn or leave a comment. #eikontx #science #engineering #therapeutics
Excited to connect with colleagues, collaborators, and the clinical oncology community at #ASCO24! #TeamEikon will be sharing updates from our EIK1001 and EIK1003 programs and hosting meetings at Exhibit Hall Booth 32116. Swing by and say hi! Discover more about our abstracts: https://lnkd.in/g2DP-vpu
-
Excited to connect with colleagues, collaborators, and the clinical oncology community at #ASCO24! #TeamEikon will be sharing updates from our EIK1001 and EIK1003 programs and hosting meetings at Exhibit Hall Booth 32116. Swing by and say hi! Discover more about our abstracts: https://lnkd.in/g2DP-vpu
-
#AI is top of mind across biopharma R&D organizations and Eikon CEO Roger Perlmutter will be on-site in New York City speaking to this important industry topic next week at the US #Pharma & #Biotech Summit hosted by Endpoints News and the Financial Times. With Andrew Dunn at the helm and a panel that includes Regeneron, Iambic Therapeutics, and Benchling, it's sure to be an engaging conversation! #FTPharma #TeamEikon
-
This Earth Day, #TeamEikon partnered with Save The Bay for a day of community volunteering in our own backyard at Eden Landing Ecological Reserve. Together, we cleared 480 pounds (!) of invasive weeds. It was not only productive but also incredibly enjoyable contributing positively to our beautiful Bay Area environment and collaborating with colleagues across different departments. A BIG thank you to everyone who brought their energy and community spirit to the day! It truly embodied the spirit of Eikon. #EarthDay #EarthMonth #CommunityService #LoveWhereYouWork #EiKare
-
+1
-
It was a privilege to connect with the cancer research community last week at #AACR24 in San Diego. #TeamEikon enjoyed sharing data from our TLR7/8 agonist program (EIK1001) and interacting with the best minds in #cancerresearch from institutions around the world. Carolyn Cho did an incredible job presenting our poster, which you can now find online at: https://lnkd.in/g2chZeyQ Next stop, #ASCO24!
-
#TeamEikon is pleased to be part of this year's Biophysical Society meeting in Philadelphia and honored to be featured in a BPS TV video showcasing how our single-molecule tracking (SMT) platform is powering our work to identify new targets and bring novel therapies to patients. If you are at #bps2024 and want to connect, reach out to Eikon CSO Daniel J Anderson. https://lnkd.in/gsUkXf_2
Revolutionizing Therapeutic Research and Development - Eikon Therapeutics
https://www.youtube.com/
-
On this International Day of Women and Girls in Science, let's embrace the vibrant tapestry of ideas that fuels scientific progress. Diversity in thought, perspective, and personality unlocks innovation – and women have demonstrably played a key role throughout history. Eikon Therapeutics is proud to champion women and girls in science and technology and today we salute their passion, dedication, and the vital role they play in helping Eikon advance breakthrough therapeutics through the purposeful integration of engineering and science. #InternationalDayofWomenandGirlsinScience #WomenInSTEM #GirlsInSTEM #InclusionInScience #February11
-
We're pleased to kick off #JPM24 by sharing some important corporate updates. Our growing pipeline and the launch of our new Eikon Systems business unit are setting the stage for another year of tremendous progress! As our CEO and Board Chair Roger Perlmutter stated in today’s announcement, “Our progress showcases the integrated clinical development capabilities of Eikon’s team and demonstrates that our proprietary instruments can identify novel chemical matter with especially desirable pharmaceutical properties. These achievements offer the promise of improved treatment outcomes in cancer patients, and in patients afflicted with intractable inflammatory or neurodegenerative conditions.” Learn more about our progress: https://lnkd.in/egQgrB38 #TeamEikon #JPM2024
-
Endpoints News' Andrew Dunn recently paid a visit to Eikon's headquarters in California where he met with our leadership team and toured our labs. It was a pleasure to share with him more about our pioneering technology and walk through the labs where #TeamEikon is hard at work advancing breakthrough therapeutics through the purposeful integration of engineering and science. Across two great articles, he highlights our progress in scaling our proprietary single-molecule tracking (SMT) platform, and how it is allowing us to explore cell and molecular biology in completely new ways and build a growing therapeutic pipeline with the potential to deliver important new medicines to address serious illnesses. https://lnkd.in/eqqqYu2x https://lnkd.in/g6UqpiPg